<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00812071</url>
  </required_header>
  <id_info>
    <org_study_id>3369-01</org_study_id>
    <secondary_id>1R01FD003369-01A1</secondary_id>
    <nct_id>NCT00812071</nct_id>
  </id_info>
  <brief_title>Phase 1B Study of RiVax, a Vaccine to Prevent the Toxic Effects of Ricin</brief_title>
  <acronym>FDA-OPD</acronym>
  <official_title>Phase 1 Study of the Safety and Immunogenicity of RiVax With Alum in Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dose escalation study: 3 dose groups. 5 patients in each dose group, then 15 more patients in
      &quot;best&quot; group. 3 vaccinations in volunteers, at 0 6 and 16 weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Final report was submitted to Dr. Karen Russell at FDA, Rockville on September 26, 2012.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>assess the safety of 3 dose levels</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>determine the immunogenicity of the 3 dose levels</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>RiVax</intervention_name>
    <description>vaccine</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy volunteers aged 18-31, m or f

        Exclusion Criteria:

          -  immunodeficiency

          -  pregnant

          -  chronic disease

          -  parental IgG

          -  abnormal labs

          -  drug use

          -  hiv

          -  hep c

          -  hep b
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>31 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lubin, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lubin Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hampton Roads Center For Clinical Research</name>
      <address>
        <city>Chesapeake</city>
        <state>Virginia</state>
        <zip>23320</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2008</study_first_submitted>
  <study_first_submitted_qc>December 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2008</study_first_posted>
  <last_update_submitted>August 19, 2013</last_update_submitted>
  <last_update_submitted_qc>August 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>Ellen Vitetta</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>volunteers</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

